nwinnovation
High Technology News and Information for the Pacific Northwest Region
Home
Mobile
News and Events
  • Headlines
  • Interviews
  • Events
  • Jobs
  • VC Funds
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
  • People
  • Exits
  • VentureMap
  • PowerSearch
  • FundingSearch
  • Stats
  • Dashboard
  • Satellite
  • Post Jobs
    • About
  • About
  • Contact Us
    		•
    Search News
    Subscribe with Bloglines Subscribe in NewsGator Online Add to My Yahoo
    Thursday, November 29, 2007

    Fate Therapeutics Launches Stem Cell Firm


    Seattle-based Fate Therapeutics said Thursday afternoon that it has launched a new biotechnology company, which will develop drugs to control cell fate. The firm said it is targeting the use of adult stem cells for healing, using small molecule drugs. The firm said it has received $12M in backing from ARCH Venture Partners, Polaris Venture Partners, Venrock, and OVP. The firm's team includes Randall Moon, the Director of the University of Washington's Institute for Stem Cell and Regenerative Medicine, along with stem cell scientists from Stanford, Scripps Research Institute, and Harvard.
    posted on Thursday, November 29, 2007 (Link to more information)


    Related companies:
    Fate Therapeutics

    Related stories:
    > Fate Therapeutics Adds CEO, Chairman
    > Cell Therapeutics to Nab Systems Medicine for $20M
    > Cell Therapeutics Finalizes Acquisition
    > Cell Therapeutics Hires President
    > CG Therapeutics Appoints Chairman, Looks For Venture Funding
    Sign up to receive updates via our daily email newsletter

    Enter your email:


    Previous Issues

     Thursday, August 28, 2008
    Wednesday, August 27, 2008
    Tuesday, August 26, 2008
    Monday, August 25, 2008
    Friday, August 22, 2008